The Future of Brain Health

Milken Institute Report Highlights

• Released a 2023 update to a 2016 report, focusing on the rising costs of dementia and disparities between men and women.
• Two-thirds of individuals living with dementia are women, creating a disproportionate burden on female caregivers.
• Recommendations include training health professionals and caregivers, improving community understanding, and accelerating the search for a cure.
• Emphasis on shifting focus from solely finding a cure to reducing risk, improving early detection, and enhancing care delivery systems.

Scientific Advances in Alzheimer's Research

• Early detection is now possible via blood tests for amyloid, imaging, and digital technologies like AI and polygenic risk scores.
• The National Institute on Aging (NIA) has secured increased federal funding, leading to a decade of growth in knowledge regarding pre-symptomatic detection.
• Current research is investigating multiple targets beyond amyloid plaques, including tau, synaptic transmission, neuroinflammation, and vascular changes.
• The "Accelerating Medicines Partnership" has renewed interest in viral links, specifically observing associations between herpes simplex virus (HSV-1) and amyloid deposition.
• New evidence suggests amyloid beta acts as an antimicrobial peptide that entombs microbes; research aims to "dial down" rather than eliminate this response.

Drug Development and Market Implications

• Biogen announced revised data for aducanumab (an amyloid-targeting drug) after an initial interim analysis deemed it failed; a subsequent analysis showed success in one of two trials.
• The drug demonstrated a potential to slow cognitive decline (shifting patients from a "black slope" to a "blue slope"), though the data is pending full review at the 2023 AD & Dementia meeting.
• Dr. Tanzi predicts potential FDA approval based on precedent for other Alzheimer's drugs, but notes significant hurdles regarding cost ($5,000/month) and access for the 38 million asymptomatic Americans with amyloid.
• The industry is expected to pivot toward developing cheaper, safer, daily oral medications that target amyloid earlier in the disease process.
• Health system leaders question the affordability and infrastructure required for widespread infusion-based treatments.

Sleep's Critical Role in Brain Health

• Sleep disorders and insufficient sleep are identified as significant risk factors for Alzheimer's, appearing decades before clinical symptoms.
• Specific sleep-wake brainwave patterns are essential for the clearance of toxic amyloid and tau proteins.
• Tools to manipulate these brainwave patterns during sleep are being developed to potentially impact pathology.
• Epidemiological data indicates seven hours of sleep is optimal; deviations (significantly more or less) correlate with increased health risks.
• Insomnia is specifically linked to Alzheimer's risk, particularly in women, who have a higher prevalence of insomnia and depression.

Healthcare System Transformation

• Over 50% of care for neurodegenerative diseases now occurs in home or ambulatory settings, necessitating a shift away from traditional hospital-centric models.
• The American Hospital Association is leading the creation of "age-friendly health systems" with specialized training for caregivers and workforce development.
• Emergency departments are identified as high-stress environments; 70% of dementia-related ED admissions do not require hospitalization, prompting calls for in-home stabilization models.
• Current payment systems often incentivize hospital transport over home-based care, creating barriers to patient stability.

Actionable Prevention Strategies (SHIELD Acronym)

• S (Sleep): Prioritize 7 hours of sleep and treat disorders like sleep apnea, which causes brain hypoxemia.
• H (Hearing & Stress): Screen for hearing loss (a significant dementia risk factor) and manage stress through meditation.
• I (Interaction): Increase social engagement across generations to combat isolation and cognitive decline.
• L (Learn): Engage in cognitive training and continuous learning to build brain resilience.
• D (Diet): Adopt heart-healthy diets (Mediterranean or MIND diet) to support the gut microbiome and brain health.
• The SPLINE study confirms that lowering blood pressure to 120 mmHg reduces mild cognitive impairment and dementia risk.

Demographic and Gender Disparities

• Women experience higher risks of Alzheimer's due to biological factors (e.g., perimenopause) and extended caregiving roles.
• Research highlights differences in sleep brainwave patterns between genders, with women often under-diagnosed for sleep apnea due to different symptom presentation.
• Non-white populations face unaddressed disparities that require further research into precision medicine approaches.

Future Outlook and Timeline

• The goal of a cure or treatment by 2025 is viewed as ambitious; experts anticipate significant impact and management strategies rather than a total cure within this timeframe.
• The field is evolving toward a multifactorial approach similar to cancer treatment, combining pharmacological interventions with lifestyle modifications.
• Upcoming NIA-supported trials aim to provide concrete evidence for non-pharmacological interventions (diet, exercise, sleep).
• A state-of-the-science review on caregiving models is scheduled for release in March, with a summit to follow on the NIH campus.